Business of Optometry News

EssilorLuxottica has signed an agreement to acquire the entire share capital of Optical Investment group, a Romanian eye wear and eye care retailer, the company announced in a press release.

Patients with dry eye disease experienced improvements in ocular discomfort after treatment with reproxalap, according to a press release from Aldeyra Therapeutics.

Ocular Therapeutix obtained FDA support to use the phase 3 SOL-R trial as the next step in the regulatory process for Axpaxli, according to a press release.

The Federal Trade Commission proposal to ban noncompete clauses for all workers has sent powerful ripples through the health care industry, prompting physicians of all specialties to reevaluate their career trajectories.

The European Commission approved Vabysmo for the treatment of visual impairment due to macular edema secondary to retinal vein occlusion, according to a press release from Roche.

The latest Vision Council Consumer inSights report highlights key generational differences in eye care, with younger generations less likely to receive their next exam within 12 months, despite an increase in vision coverage.

The FDA granted 510(k) clearance to the Faros anterior cataract surgery system from Oertli Instrumente, according to a press release.

Eyenovia and Senju Pharmaceutical Co. have announced a collaboration agreement to develop Senju’s SJP-0035 for use with Eyenovia’s Optejet dispensing technology as a combination product to treat chronic dry eye disease.

Optometry Giving Sight has launched a new program, Together Eyecare Achieves Miracles, or TEAM OGS, as a means for optometry practices to raise funds for OGS and support its mission, the nonprofit organization announced in a press release.

Merck has announced the acquisition of all outstanding shares of EyeBio, making it a wholly-owned subsidiary, according to a company press release.